To provide a sensitive and generally applicable method to de- The detection of minimal residual disease (MRD)' in the lymphoid malignancies is of fundamental importance, both in the clinical management of patients, and in order to improve our understanding of the mechanisms whereby the immune system deals with low numbers of tumor cells. Improved techniques will allow better assessment ofcomplete remission after chemotherapy, earlier detection ofrelapse, and improved analysis of the role of immune modulators in apparent complete remission. In addition, the use of autologous bone marrow transplantation is, at least theoretically, dependent on the reinfusion of bone marrow that is free of disease. Currently available methods are limited either by their sensitivity or specificity and improved techniques are clearly required (1).
Introduction
To provide a sensitive and generally applicable method to detect clonal cells in acute lymphoblastic leukemias (ALL), we have designed a new strategy based on the polymerase chain reaction (PCR) amplification of the T cell receptor y6 gene rearrangements found in most T and B lineage ALLs. PCR allows rapid sequencing of variable-(diversity)-joining (V-[D]-J) junctions from tumor DNA and construction of anti-junctional oligonucleotides (AJOs) used as probes to detect clonal cells in the same patient. We have defined oligonucleotides suitable for all T cell receptor (TCR) rearrangements involving functional Vy segments. Oligonucleotides corresponding to preferential TCR5 rearrangements in T and B lineage ALLs were also used. By analysis of the nucleotide sequence of 52 V"y-V'y junctions from 30 cases of B and T ALLs, we demonstrate that V-J junctional sequences are clone specific in both lineages and at all stages of differentiation examined despite the frequent presence of the recently described P nucleotides.
Experiments performed with TCRy5 AJOs on DNA from tumor cells and polyclonal T cells show that AJOs can be used to differentiate clonal cells from polyclonal T cells, distinguish between different T cell clones, and detect residual clonal populations at 10-4/10-5 dilution. AJOs were also used to detect residual disease in samples from patients in clinical and morphological complete remission. Finally, rearrangement patterns were studied by classical Southern analysis in selected cases at both presentation and subsequent relapse showing absence of clonal evolution in most cases. V-(D)-J nucleotide sequences of rearrangements with an identical pattern of rearrangement at presentation and relapse were identical in all cases analyzed. We therefore describe a new, specific, and clinically useful strategy for the detection of minor clonal populations applicable in the majority of cases of ALL. (J. Clin. Invest. 1990 . 86:2125-2135.) Key words: acute leukemias. minimal residual disease * T cell receptor genes -polymerase chain reaction * molecular medicine
The detection of minimal residual disease (MRD)' in the lymphoid malignancies is of fundamental importance, both in the clinical management of patients, and in order to improve our understanding of the mechanisms whereby the immune system deals with low numbers of tumor cells. Improved techniques will allow better assessment ofcomplete remission after chemotherapy, earlier detection ofrelapse, and improved analysis of the role of immune modulators in apparent complete remission. In addition, the use of autologous bone marrow transplantation is, at least theoretically, dependent on the reinfusion of bone marrow that is free of disease. Currently available methods are limited either by their sensitivity or specificity and improved techniques are clearly required (1) .
The demonstration of immunoglobin or T cell receptor ,B gene rearrangements has provided useful markers of clonality in lymphoid malignancies (2) , but their detection by Southern blot analysis is in general limited to 1-5%. The recent development of the polymerase chain reaction (PCR) (3) has allowed detection of a much lower level oftumor infiltration in certain hematological malignancies. This technique has been used to amplify and detect specific chromosomal translocations with a level of sensitivity of detection of -1 in IO'. It has thus been possible to detect residual clonal cells in those cases ofpredominantly low grade follicular, non-Hodgkin lymphomas that demonstrate a t(14;18) (4) and to detect low levels of t(9;22) RNA from cases of chronic myeloid leukemia or t (9;22) positive acute lymphoblastic leukemia (ALL) in apparent complete remission (5) .
The majority of lymphoid malignancies are not however, associated with a chromosomal translocation that has been characterized at the molecular level or that is suitable for PCR amplification. In contrast, the vast majority of these neoplasms are associated with clonal rearrangements oftheir antigen receptor genes, the structures and patterns of rearrangement of which have been extensively studied. We have undertaken to develop a system of PCR amplification of such clonal markers that would be useable in the majority ofcases ofALL. In the germline state these genes exist as discontinuous V (variable), J (joining), and in some cases, D (diversity) segments (Fig. IA) . During early lymphoid differentiation these gene segments rearrange to generate antigen receptor diversity by two main mechanisms (6): (a) combinatorial diversity due to random recombination of segments and (b) junctional diver- 1, T7; 2, T42; 3, T7; 4, T41; 5, B30; 6,  T37 (V9-JP); 7, B25; 8, B23; 9, T28; 10, T2; 11, T42; 12, T19; 13,  T14; 14, T13; 15, T21 (V8-JP1) . Primers corresponding to the rearranged V segment were used in the PCR reaction. The Jy 1/2 primer was used in all cases with the exception of T37 (JP primer used) and T21 (JPI/2 used).
sity due to imprecise V-(D)-J joining and random addition of nongermline encoded nucleotides by the TdT enzyme to form the so-called N regions (Fig. 1 B) . We reasoned that if such random junctional sequences are clone-specific markers, a strategy based on PCR amplification of rearrangements by V and J primers followed by detection with specific antijunctional oligonucleotides (AJOs) could be useful for the detection of minor clonal lymphoid populations. (8) (Fig. 1 A) . TCRy contains 15 V segments, only 10 of which have been shown to undergo rearrangement. These rearranging V segments can be subdivided into those belonging to the VyI family (Vy2,3,4,5,8) and the V'yII (Vy9), VyIII (V 10) , and VyIV (Vy 11) families (9) (10) (11) (12) (13) (14) . The highest levels of homology exist between Vy2 and V'y4, Vy3 and Vy5, since they represent recent duplication events (14) . Of the 5 J segments (9, (15) (16) (17) , two highly homologous segments (Jy 1 and Jy2) are used in the vast majority of T and B lineage ALLs (1 1). The nucleotide sequences of all these V and J segments are known (see Table II for reference).
The TcRb locus is also well characterized. To date, 6 V, 3 D, 3 J segments, and 1 constant region have been described (18) (19) (20) (21) (22) . The TcRb genes are localized on chromosome 14 (band q 11) and are situated within the TcRa gene between the V and J regions (19, (21) (22) (23) (24) . TCRa rearrangement is therefore associated with TCR6 deletion on that allele. Due to the limited combinatorial diversity of TCR'yO genes, V and J segment utilization and the choice of amplification primers can be determined from the pattern of DNA restriction fragments observed on Southern blot analysis using a limited number of probes and restriction endonuclease digests (12) . In contrast to the limited germline encoded diversity, extensive junctional diversity has been demonstrated in TCRy and TCRb rearrangements by analysis of thymocyte and peripheral T cell libraries (25) (26) (27) (34) . P nucleotides are underlined. "Rearranged to JPI; 'rearranged to JP (see Fig. 1 ). IIR, rearrangement not assigned; G, germinal configuration. Del V, number of nucleotides deleted from the 3' part of the V segment; del J, number of nucleotides deleted from the 5' part of the J segment.
of B lineage, implying that diagnostic tools based on these rearrangements are ofgeneral interest in ALL. TCRy genes are rearranged on at least one allele in 40-70% ofcases ofB lineage ALL including common CD10+ ALL. TCRb genes are rearranged or deleted in 90% of T ALL and in 70-100% of B lineage ALL (28) (29) (30) .
We have previously shown in a preliminary report (31) that PCR amplification of a particular TCRy rearrangement (i.e., Vy9-Jy) in two cases of ALL, followed by cloning and sequencing of the V-J junction, allowed the construction of an antijunctional oligonucleotide (AJO) and its use to detect clonal cells at a 10-' dilution into germline DNA. However, the V'y9 segment analyzed in this study is the sole member of the VyII subgroup representing only 10% ofrearrangements in ALLs according to our experience. It therefore remained to demonstrate that this strategy would be generally applicable in all TCRy rearrangements, particularly in those cases undergoing rearrangements involving the highly homogenous members of the Vyl family.
In cases undergoing the preferential VA 1-J6 1 rearrangement (30). We also report that the method can be rendered more rapid by using double-stranded sequence analysis. Finally, we demonstrate the general specificity sensitivity and clinical applicability of the use of AJO's for the detection of clonal lymphoid populations.
Methods
Cells. DNA from 23 cases ofT-ALL and 7 cases of B lineage ALL were analyzed (Table I ). All cases were defined by standard morphological criteria, with all T-ALLs expressing the CD7 antigen and the B lineage cases the CDl9 molecule. Full immunophenotypic characterization has been described elsewhere (28, 30, 32) , where relevant patient numbers correspond to those in previous publications. Polyclonal T cells were obtained by density gradient centrifugation on Ficoll Hypaque and classical sheep red blood cell rosetting. Southern analysis of TCR'y6 rearrangements. Southern blots and study of rearrangements were performed using J-y and J6 probes on Bam HI, Hind III, Eco RI, and Kpn I digests (30) . Analysis of V'y rearrangements was performed as previously described (1 1) using Jy and specific Vy probes, and the V and J segments involved determined from the patterns obtained.
PCR amplification. PCR amplification of 1 ,ug DNA was performed for 35 cycles, using the strategy previously described (33), using V and J primers specific for the segments shown to be involved on Southern blot analysis (Table II) . As use of Jy 1 vs. JPy2 is sometimes difficult to define (28) and as the nucleotide sequences of these segments are nearly identical, a common oligonucleotide (Jy2S2) has been used as primer. A common JyP1/2 oligonucleotide has been used for JPl and JP2 rearrangements. The quantity of oligonucleotide used for amplification of presentation DNA was 10 pm each and for detection of minimal residual disease was 30-40 pm, since we have found that the lower concentration is more specific but insufficiently sensitive for the detection of rare events (data not shown). Polyclonal T cell control DNA was included to exclude the possibility that use of the slightly higher concentration of oligonucleotides led to nonspecific false positive responses. The temperature of annealing corresponded to the lower temperature of the two oligonucleotides used (55-57°C). After amplification, samples were analyzed by 6% PAGE and ethidium bromide staining and by dot blot hybridization with 32P-labeled probes as previously described (33) . In all cases the specificity of amplification was confirmed by verification of the Vy/V6 segment involved both by using Vy/Vb specific internal primer prefaced by T in Table II as sequencing primers, and directly from the Vy/V6 sequence data obtained. Separation of biallelic rearrangements on PAGE was performed by excision of the ethidium bromide-stained band and direct reamplification of 25% of the excised gel block for 15 cycles.
Sequences analysis. Direct double-stranded sequencing was performed as previously described (33) using 20-30 ng V-y-specific internal primers (TVy in Table II ) 5' labeled with 32p. In selected cases sequencing was performed after cloning of amplified products into Ml 3 blunted, using 5' kinased oligonucleotides. Sequencing was performed by the sequenase method using Vy and Jy 1/2 internal primers and 35S-ATP. All sequences were performed on at least two occasions from separate PCR reactions. We therefore undertook to develop a strategy in which the amplification would be as specific as possible for one of the two alleles, in order to maximize the sensitivity of detection of clonal cells by specific AJO probes. Anti-V segment amplification oligonucleotides were therefore selected in order to exploit differences in nucleotide sequence between Vy segments near their 3' ends. The V and J segments involved in rearrangement had previously been determined from Southern blotting and probing with Jg and Jd probes (11, 28, 32 , and data not shown). In some cases the efficacy of amplification was unsatisfactory and new primers were designed. The location of the primers eventually used, as well as the references describing the germline Vy sequences are shown in Table II . As we have previously demonstrated, the nucleotide sequences of V,y4/V'y2 and Vy3/Vy5 are > 98% homologous (14) . It was therefore not possible to construct highly specific primers for those Vy segments.
The Vy and Jy primers were used to PCR amplify presentation DNA from over 50 TCR'y rearrangements in 31 cases of T and B lineage ALL, most of them being performed on DNA with distinct rearrangements on each TCRy alleles. It was possible to amplify rearrangements involving all Vy segments known to be capable of producing a functional protein (Vy2, 3, 4, 5, 8, 9, 10, and 1 1) and rearrangements using JPy1, JPy2, JP, and JPI (Fig. 1 C) . An amplification oligonucleotide that recognized both Jy1 and Jy2 was used in cases using this segment. In all but those cases with Vy2-J'y/Vy4-Jy configuration, specific amplification was obtained. A representative set of experiments analyzed by polyacrylamide gel electrophoresis is shown in Fig. 1 C. Note that, as we have previously described for VA1-J61 rearrangements (33) , PCR amplification of rearrangements involving the same V-J combination on both alleles leads to formation of large fragments probably corresponding to heterodimers (Fig. 1 C, 9±SD 4.3) . Deletions ofthe 5' part ofJy seemed to be more extensive, ranging from 0 to 22 (mean 6.6±SD 4.9) ( Table I ). There was no correlation between the number of nucleotides deleted from the V and the J segments. In 16/52 rearranged alleles no deletion of the V segment was observed. Putative P nucleotides (34) were noted in 8 of these cases (see Discussion). The same pattern was observed for all cases, there being no deletion in the 5' end of the J segment (Table I) . Addition of nongermline encoded nucleotides (N regions) were noted in all but two cases. The number of added nucleotides ranged from 0 to 17 (mean±SD, 5.9±3.9). The nucleotide composition of N regions was highly variable with a GC content of 55.1% (P nucleotides excluded from the calculation). No differences in the extent of deletion/addition or in the GC content of N regions were observed between junctional sequences involving different V'y segments. There was no difference in the GC content of in-frame and out-of-frame rearrangements.
The number of nucleotide deletions/additions was no different when T and B lineage ALLs were compared, nor was there any difference between immature (CD3-) and mature (CD3+) T-ALLs. In contrast, comparison of CD3+a,3 and yb expressing cases showed a lower number of added nucleotides in the latter group (Table I) . Approximately one-third (36%) of rearrangements were in-frame and free of stop codons and were considered as potentially functional. All junctional sequences were unique.
These data show that, although they are less extensive than We first verified that AJO were able to recognize their corresponding targets after PCR amplification. 21 AJO were synthesized and used as described in Methods. As expected, specific hybridization was observed in each case (Fig. 2 and data not shown).
We next examined the reactivity of AJO against PCR amplified DNA from various purified polyclonal T cell samples. (Table III) . Table III for definition). Dot blots were hybridized with AJO directed against the corresponding TCR-y rearrangements.
peripheral blood mononuclear cells containing occasional stem cells obtained by leukapheresis during postchemotherapy regeneration. For two patients (T10 and T19), longitudinal studies were performed including at least one sample obtained in apparent complete remission. In two cases (T19a, T38a, b; Fig. 4 ), positive hybridization with the corresponding AJO probe was observed, strongly suggesting the presence of residual malignant cells. Both positive clinical samples were taken early in remission. One of these patients (T38) relapsed soon afterwards. It is noteworthy that a subsequent sample taken from patient T 19 two years later was negative with no evidence of disease at a 10-' dilution. Two of three negative samples were taken later on in remission. In four of the five cases, similar results were found with both AJOs. There was however, a discrepancy in the results with the two AJOs in T38 (see below). It is noteworthy that some discrepancies in the evaluation of the number of malignant cells (in the range of one log dilution) were observed, showing that quantification should be considered as only approximate. Limitations ofAJO usefor the detection ofMRD. The use of AJO in detecting minimal residual disease assumes that an identical rearrangement(s) exists in all malignant cells and that no alteration of rearrangement patterns occurs between presentation and subsequent relapses. To test this hypothesis, nine cases of B (two cases, B 13 and B5, not shown in Table I) or T lineage ALLs (seven cases, T14, 26, 31, 41, 38, 39, see Table I ) were studied at presentation and at first relapse. 14 TCRy and 12 TCRb alleles were analyzed (excluding germline alleles). In 2 instances, alterations were observed. In 1 case (T39) the TCRy genotype was Vy8/Vy8 at presentation and V'y8/V'y4 at the first relapse. In another case (T38) a partial VA 1-Jb 1 rearrangement was detected at presentation but complete deletion of this allele was demonstrated at relapse. This explains why the anti-TCR V61 AJO failed to detect MRD while the anti-Vy8 AJO was positive (see above).
Of those cases with an identical pattern of rearrangement on Southern blotting at presentation and relapse, 13 alleles (lOy, 36) were amplified and shown to have identically sized V-(D)-J junction by PAGE. Sequence analysis of 4 of these rearrangements (T31 V6 1 [2 alleles], T31 V'y8, T41 Vy 11) confirmed identical sequences (not shown).
Discussion
In this paper we show that AJOs, which recognize TCRyb V-(D)-J junctions, provide sensitive and specific clonal probes that can be used in the majority of cases of ALL ofboth T and B cell lineage. We had previously shown in preliminary experiments (31) that it was possible to amplify a particular TCRy rearrangement and, by cloning the V-J junctions, construct an AJO that could detect residual clonal cells. There was, however, a discrepancy in the level of sensitivity of detection on dilution of clonal DNA into germline DNA and into polyclonal DNA. An additional disadvantage was that cloning of amplified products before sequencing can be relatively time consuming. It remained to demonstrate that TCRy junctional sequences in the majority ofcases are sufficiently clone specific in ALL, to determine whether our strategy could be used in other TCRyb rearrangements, and finally to test the clinical applicability of our procedure.
By analysis of a large number of clonal neoplastic cells, we showed here that TCRy V-J junctional sequences are indeed clone specific. We have previously shown that direct sequencing of TCRb rearrangements in ALL is feasible (33) . In this study we analyzed over 50 TCRy alleles using the same strat- (34) that recurrent mono-or dinucleotides (also named P nucleotides, P standing for palindrome) occur frequently in V-(D)-J junctions of rearranging genes. These nucleotides form a palindrome with the immediately adjacent germlineencoded nucleotides and are only observed if the corresponding gene segment appears in its full sequence in the coding joint. It was proposed that such nucleotides are due to a single-strand dinucleotide cleavage of the 5' end of the rearranging segment followed by the joining to the 3' end of the other strand. One or two P nucleotides are observed in the junctional sequence if no subsequent deletion occurs (resulting in two P nucleotides) or if the deletion is limited to a single nucleotide (resulting in one P nucleotide). Examination of our data confirm these observations. Putative P nucleotides are observed in a number of cases for which the rearranging gene segment (V or J) appears in its full germline sequence (15/23 alleles). Note however that the overall random nature of the junctional sequences is not greatly alterated by this phenomenon (Table I) .
Having demonstrated that TCRy and a junctional regions are highly clone specific, we then used AJOs to distinguish amplified clonal DNA from other clones using the same V and J segments and from polyclonal T cells. These AJOs were also The choice of the rearrangement to be used as the clonal marker in our strategy may depend of the number of polyclonal T cells present in the samples. We initially showed that the presence of irrelevant amplifiable rearrangements leads to a diminution in the level of sensitivity of detection of TCRy rearrangements (31). Experiments performed during this study suggest that this is due to consumption of reagents. In order to minimize this problem, it was important to develop a strategy that was as allele specific as possible. Using a bank of 11 oligonucleotides as amplification primers and 8 internal V segment-specific probes and sequencing primers, it was possible to specifically amplify all rearrangements other than those cases that demonstrated Vy2 or Vy4 rearrangements, since these two genes are greater than 98% homologous (14) . The use of a V-specific amplification procedure minimizes the decrease of sensitivity due to contaminating polyclonal T cells. We show that the presence of 10% polyclonal DNA leads however to a minimal decrease, suggesting that the numbers of T lymphocytes found in remission bone marrow are unlikely to be a major problem. It does, however, limit the use of this TCRy amplification for the analysis of peripheral blood samples, although the small amount of DNA required means that the majority of polyclonal T cells could be removed by SRBC rosetting in all B lineage ALLs and in the few cases of CD2-T-ALLs before analysis. Ifremoving ofpolyclonal T cells is not practicable, it is preferable to use probes against V-D-J TCRb sequences. The theoretical advantage of using this system is the fact that the majority of peripheral blood T cells (a(3 expressing) have deleted TCRb usually on both alleles (35) . Biallelic deletions are observed in only 25% of either B or T ALLs (30) . We have shown that TCR5 rearrangements involving the predominant Vb 1-J6 1 rearrangement occurring in T-ALLs can be amplified. PCR amplification of TCRb can also be used in B lineage ALL since the predominant rearrangement in these cases involves V62-D63 (11/22 rearranged alleles, unpublished observations). They can be PCR amplified using, for example, the oligonucleotides shown in Table II A potential problem of PCR amplification-based strategies for the detection of minimal residual disease lies in the possibility of false positive results due to contamination of samples by amplified products (37) . The allele-specific nature of the amplifications and the clone-specific AJOs used in the strategy described here will limit false positives to those samples contaminated with the patients own presentation DNA or amplified products, although contamination with a different patient sample undergoing rearrangement with the same V and J segments will lead to a diminution of sensitivity due to "competition" for oligonucleotides. To minimize these problems we feel that, in addition to all the general precautions necessary to avoid contamination (37), patients should, if possible, be analyzed with two separate AJOs.
A limitation specific to AJO-based strategies is the possibility of alteration in the rearrangement pattern, either due to emergence ofa subclone or to clonal evolution in the predominant blast population. In certain cases coexistence of minor populations have been observed even at presentation by Southern blotting (38) , limiting the use of AJOs for these clones in these cases. We have demonstrated alteration in -10% of TCRyb alleles in this study, which is similar to the incidence of clonal evolution of immunoglobulin heavy and light chains reported by Wright et al. (39) . No patient, however, demonstrated evolution of more than one allele, suggesting that false negatives due to clonal evolution are unlikely if more than one AJO is used.
An alternative strategy based on the use of PCR amplification of TCRy or TCRO junctional regions has been briefly reported by Tyko et al. (40) . It is similar to that described here in that the presentation DNA is amplified, albeit using consensus primers, and sequenced after cloning of the amplified products. The junctional region ofthe TCRy rearrangement is then used as a target for a second "clone-specific" amplification using a junctional-specific amplification oligonucleotide with the 3' end of the oligonucleotide directed to the N nucleotides. These amplified fragments were then analyzed with Vy, but not clone-specific probes. This strategy has the theoretical advantage of only amplifying the clonal rearrangement.
To verify that the fragments amplified are indeed those of the original clone, it would be preferable to be able to construct an additional internal AJO clone-specific probe that does not overlap with the amplification antijunctional oligonucleotide. This is possible with the extensive junctional diversity of complete V-D-J TCR6 rearrangements, as found predominantly in T lineage but not in B lineage ALL. It's use for TCRy rearrangements is however limited by the more restricted nature of these junctions, as shown here. Moreover, the highly AT-rich nature of the 5' end of TCRy J 1/2 segments, as found in the vast majority of TCRy rearrangements, means that the temperature of these antijunctional oligonucleotides will be low. Since all specificity in this strategy must occur at the time of amplification, the disparity of the temperatures of the anti-V and antijunctional oligonucleotides will limit specificity. We have found that the use of this strategy is associated with nonspecific amplification of polyclonal T cells in all but highly stringent conditions of amplification, and feel that this limits the use of this method in practice.
In practical terms, the method which we described here takes -11 d for the first step (obtaining the specific AJO). This includes Southern blot analysis of presentation DNA (8 d) , initial PCR amplification (1 d), and direct sequencing (2 d). This estimate depends on the availability of commercially manufactured oligonucleotides, and is obviously minimized if oligonucleotides are synthesized and purified in the laboratory. Specific AJOs can be synthesized once and stored for subsequent use for the same patient during follow-up. Testing of clinical samples (i.e., amplification of remission DNA) takes only a few hours.
Our strategy could be shortened at several stages. Firstly, PCR based assignment of V and J segments will obviate the need for Southern blot analysis. Secondly, the use of uncharacterized, labeled, amplified presentation DNA fragments could be used as clone-specific probes as recently shown for the Vl-J 1I rearrangement by Hansen-Hagge et al. (41) . These modifications of the use of AJOs may render our strategy useable in less specialized clinical laboratories, allowing the longitudinal study oflarge numbers ofpatients in order to assess the prognostic significance of low levels of persistent clonality.
